How much do you think a CEO of this caliber is worth per annum ?
Maybe you’d prefer someone that’s happy to earn just above the fry cook at McDonald’s steering your global enterprise ?
Your short term thinking may cripple your future.
Background
Dr. Miriam Halperin Wernli, also known as Miri, Ph.D., MBA is a Co-Founder of Creso Pharma Limited and serves as its Chief Executive Officer and Managing Director. Dr. Wernli is a senior pharmaceutical and biomedical executive with over 25 years of strategic and operational leadership in the biopharmaceutical industry and a deep understanding of drug and product development. Dr. Wernli has held worldwide senior leadership positions in product development, R&D and Strategic Marketing throughout Switzerland and in the US (Merck, Sharp and Dohme, Roche and Actelion pharmaceuticals). Her extensive pharmaceutical industry and biomed research and development experience covers the full spectrum of areas and activities from Preclinical to Clinical Development and Strategy, to Drug Registration and Launch, across several Therapeutic Areas. Dr. Wernli is an experienced Pharmaceutical leader with skills and broad expertise in Drug Development, Regulatory Affairs, Project & Portfolio Management, Development Finance & Controlling and Corporate Strategy and Governance. She has depth of experience in Pharma drug development as well as her leadership roles in complex highly regulated health environments in Europe and the US. She has been a Director at Creso Pharma Limited since November 2015.
